Oculis Holding AG (OCS) Assets Average (2023 - 2026)
Oculis Holding AG (OCS) posted quarterly Assets Average of $303.4 million for Q1 2026, up 66.49% year-over-year from $182.2 million in Q1 2025, and up 20.15% quarter-over-quarter from $252.5 million in Q4 2025.
Oculis Holding AG (OCS) Assets Average (2023 - 2026) Analysis & Trends
Oculis Holding AG's Assets Average history runs 4 years deep, the most recent figure standing at $303.4 million for Q1 2026.
- In Q1 2026, Assets Average rose 66.49% year-over-year to $303.4 million; the TTM figure through Mar 2026 stood at $303.4 million (up 66.49% YoY), while the FY2025 annual figure was $210.7 million, up 59.54% from the prior year.
- Assets Average for Q1 2026 stood at $303.4 million, up from $252.5 million in the prior quarter.
- The five-year high for Assets Average was $303.4 million in Q1 2026, with the low at $121.0 million in Q1 2024.
- The 4-year median for Assets Average is $149.2 million (2024), against an average of $182.4 million.
- The sharpest annual moves came in 2024 and 2025: Assets Average advanced 0.82% in 2024, then jumped 78.86% in 2025.
- Oculis Holding AG's Assets Average stood at $137.4 million in 2023, then gained by 2.72% to $141.2 million in 2024, then surged by 78.86% to $252.5 million in 2025, then advanced by 20.15% to $303.4 million in 2026.
- Business Quant data shows OCS's Assets Average at $303.4 million in Q1 2026, $252.5 million in Q4 2025, and $214.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Oculis Holding AG | 879.09 Mn | 590.21 Mn | - | 314.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 314.16 Mn |
| Mar 31, 2026 | 303.40 Mn |
| Dec 31, 2025 | 252.52 Mn |
| Sep 30, 2025 | 214.60 Mn |
| Jun 30, 2025 | 223.23 Mn |
| Mar 31, 2025 | 182.24 Mn |
| Dec 31, 2024 | 141.18 Mn |
| Sep 30, 2024 | 149.19 Mn |
| Jun 30, 2024 | 133.25 Mn |
| Mar 31, 2024 | 121.01 Mn |
| Dec 31, 2023 | 137.45 Mn |
| Sep 30, 2023 | 147.98 Mn |